Changes in Cognitive Impairment in the Czech Republic.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 15 10 2019
medline: 1 12 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

Studies from North America and Western Europe suggest stable or declining trends in impaired cognition across birth cohorts. We aimed to examine changes in the age-specific prevalence of cognitive impairment in the Czech Republic. The study used two samples from the population-based Czech Survey on Health, Ageing and Retirement in Europe. Age-specific prevalence of cognitive impairment (defined based on scores in verbal fluency, immediate recall, delayed recall, and temporal orientation) was compared between participants in wave 2 (2006/2007; n = 1,107) and wave 6 (2015; n = 3,104). Logistic regression was used to estimate the association between the wave and cognitive impairment, step-wise adjusting for sociodemographic and clinical characteristics. Multiple sensitivity analyses, focusing on alternative operationalizations of relative cognitive impairment, impact of missing cognitive data, and survival bias, were carried out. The most conservative estimate suggested that the age-specific prevalence of cognitive impairment declined by one fifth, from 11% in 2006/2007 to 9% in 2015. Decline was observed in all sensitivity analyses. The change was associated with differences in physical inactivity, management of high blood cholesterol, and increases in length education. Older adults in the Czech Republic, a country situated in the Central and Eastern European region, have achieved positive developments in cognitive aging. Longer education, better management of cardiovascular factors, and reduced physical inactivity seem to be of key importance.

Sections du résumé

BACKGROUND
Studies from North America and Western Europe suggest stable or declining trends in impaired cognition across birth cohorts.
OBJECTIVE
We aimed to examine changes in the age-specific prevalence of cognitive impairment in the Czech Republic.
METHODS
The study used two samples from the population-based Czech Survey on Health, Ageing and Retirement in Europe. Age-specific prevalence of cognitive impairment (defined based on scores in verbal fluency, immediate recall, delayed recall, and temporal orientation) was compared between participants in wave 2 (2006/2007; n = 1,107) and wave 6 (2015; n = 3,104). Logistic regression was used to estimate the association between the wave and cognitive impairment, step-wise adjusting for sociodemographic and clinical characteristics. Multiple sensitivity analyses, focusing on alternative operationalizations of relative cognitive impairment, impact of missing cognitive data, and survival bias, were carried out.
RESULTS
The most conservative estimate suggested that the age-specific prevalence of cognitive impairment declined by one fifth, from 11% in 2006/2007 to 9% in 2015. Decline was observed in all sensitivity analyses. The change was associated with differences in physical inactivity, management of high blood cholesterol, and increases in length education.
CONCLUSION
Older adults in the Czech Republic, a country situated in the Central and Eastern European region, have achieved positive developments in cognitive aging. Longer education, better management of cardiovascular factors, and reduced physical inactivity seem to be of key importance.

Identifiants

pubmed: 31609688
pii: JAD190688
doi: 10.3233/JAD-190688
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-701

Auteurs

Dominika Seblova (D)

Aging Research Center, Karolinska Institutet & Stockholm University, Stockholm, Sweden.
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.

Carol Brayne (C)

Department of Public Health and Primary Care, Cambridge Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.

Vendula Machů (V)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University Prague, Faculty of Science, Prague, Czech Republic.
University of Groningen, Faculty of Medical Sciences, Groningen, Netherlands.

Marie Kuklová (M)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University Prague, Faculty of Science, Prague, Czech Republic.

Miloslav Kopecek (M)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University Prague, Third Faculty of Medicine, Prague, Czech Republic.

Pavla Cermakova (P)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University Prague, Third Faculty of Medicine, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH